Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia

Chemerin is dysregulation in numerous solid cancers. However, only little is known about the role of chemerin in acute myeloid leukemia (AML). In this study, we aimed to investigate the expression and clinical significance of recently described chemerin in acute myeloid leukemia (AML). The expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Zhou, Jiao, Tang, Xi, Zhou, Ling-Yu, Zhai, Ling-Ling, Vanessa, Minse Evola-Deniz, Yi, Jing, Yi, Yun-Yun, Lin, Jiang, Qian, Jun, Deng, Zhao-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696201/
https://www.ncbi.nlm.nih.gov/pubmed/29190935
http://dx.doi.org/10.18632/oncotarget.21440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696201/
https://www.ncbi.nlm.nih.gov/pubmed/29190935
http://dx.doi.org/10.18632/oncotarget.21440

Ejemplares similares